Clinical Trial Update: Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant intravenous iron therapy during erythropoietin treatment for anemia in patients with lymphoproliferative disorders has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Erythropoietin (erythropoietin)
• Intravenous iron therapy (iron (intravenous))

Snippet

Sponsor: Sundsvall Hospital | Conditions: Anemia, Multiple Myeloma | Phase 3 | Status: COMPLETED